Differences

This shows you the differences between two versions of the page.

--- home:diseases:co-infections [07.03.2011] – paulalbert
+++ home:diseases:co-infections [01.03.2012] – external edit 127.0.0.1
@@ Line 48: / Line 48: @@
 <relatedarticle> [[home:pathogenesis:innate_immunity|Innate immune response and Th1 inflammation]]  </article>
+<blockquote>
+I used to think that herpes erupted when immunity was down but I have now witnessed too many shingles outbreaks in Marshall Protocol patients as they recovered. Called IRIS or Immune Recovery Inflammatory Syndrome, this is also seen in AIDS patients as their immunity recovers.
+//**Greg Blaney, M.D.**//</blockquote>
 Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including "co-infections." One important component of the innate immune response is the antimicrobial peptides.
@@ Line 53: / Line 63: @@
 {{section>:home:pathogenesis:innate_immunity#antimicrobial_peptides_target_fungi_and_viruses&noheader}}
+Some evidence has emerged that using a therapy to target a given infection aids the body in its ability to eliminate otherwise unrelated pathogens. For example, a 2011 //Science// study gave two groups of mice an injection of poliovirus, a gut virus. One group was treated with antibiotics, thus depleting their intestinal microbiome. This group was less susceptible to poliovirus disease and supported minimal viral replication in the intestine. Further, the pathogenesis of reovirus, an unrelated gut virus, was also more severe in the presence of intestinal microbes.(({{pubmed>long:2199839}}))

home/diseases/co-infections.txt · Last modified: 09.14.2022 by 127.0.0.1